These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9123678)

  • 1. [Benign prostatic hyperplasia--the outcome of age-induced alteration of androgen-estrogen balance?].
    Weisser H; Krieg M
    Urologe A; 1997 Jan; 36(1):3-9. PubMed ID: 9123678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Androgen and estrogen metabolism in human benign prostatic hyperplasia (BPH)].
    Krieg M; Weisser H; Tunn S
    Verh Dtsch Ges Pathol; 1993; 77():19-24. PubMed ID: 7511279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential activities of androgen metabolizing enzymes in human prostate.
    Krieg M; Weisser H; Tunn S
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):395-400. PubMed ID: 7542902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid hormones and the pathogenesis of benign prostatic hyperplasia.
    Griffiths K; Eaton CL; Harper ME; Peeling B; Davies P
    Eur Urol; 1991; 20 Suppl 1():68-77. PubMed ID: 1722166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
    Krieg M; Nass R; Tunn S
    J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5 alpha-reductase inhibition by finasteride (Proscar) in epithelium and stroma of human benign prostatic hyperplasia.
    Weisser H; Tunn S; Debus M; Krieg M
    Steroids; 1994 Nov; 59(11):616-20. PubMed ID: 7535480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibition of androstenedione 5alpha-reduction by finasteride in epithelium and stroma of human benign prostatic hyperplasia.
    Weisser H; Krieg M
    J Steroid Biochem Mol Biol; 1998 Oct; 67(1):49-55. PubMed ID: 9780029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
    Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M
    J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
    Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of androstenedione 5 alpha-reductase in epithelium and stroma of human prostate.
    Weisser H; Krieg M
    Steroids; 1997; 62(8-9):589-94. PubMed ID: 9432753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dihydrotestosterone and the role of 5 alpha-reductase inhibitors in benign prostatic hyperplasia].
    Bartsch G; Rittmaster RS; Klocker H
    Urologe A; 2002 Sep; 41(5):412-24. PubMed ID: 12426858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
    Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
    J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous androgen levels in epithelium and stroma of human benign prostatic hyperplasia and normal prostate.
    Bartsch W; Krieg M; Becker H; Mohrmann J; Voigt KD
    Acta Endocrinol (Copenh); 1982 Aug; 100(4):634-40. PubMed ID: 6181638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aging on kinetic parameters of 5 alpha-reductase in epithelium and stroma of normal and hyperplastic human prostate.
    Tunn S; Hochstrate H; Grunwald I; Flüchter SH; Krieg M
    J Clin Endocrinol Metab; 1988 Nov; 67(5):979-85. PubMed ID: 2460487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of dihydrotestosterone in benign prostatic hyperplasia.
    Carson C; Rittmaster R
    Urology; 2003 Apr; 61(4 Suppl 1):2-7. PubMed ID: 12657354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratissular androgens in benign prostatic hyperplasia and prostatic cancer.
    Voigt KD; Bartsch W
    J Steroid Biochem; 1986 Nov; 25(5B):749-57. PubMed ID: 2433505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity.
    Imperato-McGinley J; Gautier T; Cai LQ; Yee B; Epstein J; Pochi P
    J Clin Endocrinol Metab; 1993 Feb; 76(2):524-8. PubMed ID: 8381804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.